# Transcat Inc. (TRNS)

**Exchange:** NASDAQ  
**Sector:** Industrials  
**Market cap:** $845M  
**Price:** $90.13 (+2.37%)

> Transcat Inc. is a leading provider of accredited calibration services, cost control, and optimization services, along with value-added distribution of professional-grade handheld test, measurement, and control instrumentation. The company specializes in serving highly regulated industries where precision and equipment reliability are critical, including life sciences such as pharmaceutical, biotechnology, medical device, and other FDA-regulated sectors. It also supports industrial manufacturing, energy and utilities like oil and gas, chemical manufacturing, and FAA-regulated businesses in aerospace and defense, as well as other sectors facing high costs from equipment failure or process inaccuracies. Transcat Inc. delivers calibration expertise to ensure measurement accuracy and compliance, while distributing specialized instruments for testing and control applications. These services and products help clients maintain operational integrity and regulatory adherence across diverse manufacturing and production environments. Founded in 1964, the company operates primarily in the United States, focusing on industries requiring stringent quality and precision standards.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $332M | $108M | $13M | $5M | $0.57 |
| 2025 | $278M | $89M | $18M | $15M | $1.57 |
| 2024 | $259M | $84M | $20M | $14M | $1.63 |
| 2023 | $231M | $68M | $16M | $11M | $1.40 |
| 2022 | $205M | $58M | $14M | $11M | $1.50 |
| 2021 | $173M | $46M | $11M | $8M | $1.03 |
| 2020 | $173M | $42M | $11M | $8M | $1.08 |
| 2019 | $161M | $39M | $10M | $7M | $0.95 |
| 2018 | $155M | $37M | $9M | $6M | $0.81 |
| 2017 | $144M | $35M | $8M | $5M | $0.64 |
| 2016 | $122M | $29M | $6M | $4M | $0.58 |
| 2015 | $124M | $29M | $7M | $4M | $0.57 |
| 2014 | $119M | $30M | $7M | $4M | $0.54 |
| 2013 | $112M | $27M | $6M | $4M | $0.49 |
| 2012 | $110M | $27M | $5M | $3M | $0.43 |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2026 | $480M | $180M | $301M | $5M | $100M |
| 2025 | $385M | $98M | $287M | $2M | $31M |
| 2024 | $288M | $62M | $225M | $20M | $2M |
| 2023 | $196M | $96M | $100M | $2M | $47M |
| 2022 | $178M | $92M | $86M | — | $46M |
| 2021 | $132M | $57M | $75M | $560,000 | $17M |
| 2020 | $128M | $61M | $67M | $499,000 | $28M |
| 2019 | $105M | $46M | $60M | $788,000 | $19M |
| 2018 | $97M | $45M | $51M | $577,000 | $21M |
| 2017 | $92M | $49M | $43M | $842,000 | $26M |
| 2016 | $77M | $38M | $39M | $641,000 | $19M |
| 2015 | $62M | $28M | $34M | $65,000 | $12M |
| 2014 | $54M | $24M | $30M | $23,000 | $8M |
| 2013 | $55M | $23M | $32M | $406,000 | $8M |
| 2012 | $45M | $18M | $27M | $32,000 | $3M |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2026 | $35M | $15M | $20M |
| 2025 | $39M | $13M | $26M |
| 2024 | $33M | $13M | $19M |
| 2023 | $17M | $9M | $8M |
| 2022 | $18M | $10M | $7M |
| 2021 | $24M | $7M | $17M |
| 2020 | $12M | $7M | $5M |
| 2019 | $13M | $7M | $6M |
| 2018 | $10M | $6M | $4M |
| 2017 | $8M | $5M | $2M |
| 2015 | $4M | $4M | $939,000 |
| 2014 | $8M | $2M | $6M |
| 2013 | $5M | $3M | $3M |
| 2012 | $6M | $1M | $5M |
| 2011 | $3M | $2M | $926,000 |

Source: [CompaniesByCap](https://companiesbycap.com/company/TRNS)